Sagimet Biosciences Inc. - Series A
About
7.27USD+0.05 +0.69%
Closed • Updated at 00:49 GMT+00:00Market Cap$444.81M
Volume646.0K
Beta2.27
RSI53.98
Sagimet Biosciences Inc. - Series A — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 12 2026
Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 11 2026
Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago
Apr 27 2026
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
Apr 27 2026
Sagimet Biosciences Provides Strategic and Corporate Updates
Recent Videos
POTENTIAL UPSIDE | SGMT STOCK ANALYSIS | SAGIMET BIOSCIENCES STOCK
Apr 30, 2026
Sagimet Biosciences: Strategic Financing and Acne Pipeline Analysis SGMT $SGMT #SGMT #stockmarket
Apr 27, 2026
How to Invest in Sagimet Biosciences Inc-A (SGMT) Step by Step
Mar 12, 2026
My Key Takeaway from Sagimet Biosciences' 8-K Filing
Dec 22, 2025
Community Chat
Ask AI
Try asking